MedTrace Logo

Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure

NCT06400927 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-07-29

No results posted yet for this study

Summary

The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.

Conditions

Interventions

OTHER

HF-guided VA

VA guided recommendation

OTHER

Standard-of-care

Standard-of-care

Sponsors & Collaborators

  • Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy

    collaborator UNKNOWN

  • East and North Hertfordshire NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Diana A Gorog, MD, PhD · East and North Hertfordshire NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-07
Primary Completion
2027-06-13
Completion
2027-09-13

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06400927 on ClinicalTrials.gov